Skip to main content
. 2019 Apr 23;11:3493–3509. doi: 10.2147/CMAR.S195137

Figure 2.

Figure 2

Elevated SMARCE1 expression indicates poor prognosis in GC patients.

Notes: (A) Representative image of SMARCE1 immunohistochemical staining in 122 paired NT and human GC samples. Up: magnification ×100; down: magnification x400. (B) High SMARCE1 expression showed poor survival in GC patients in TCGA dataset. (C) The Kaplan–Meier curve and log-rank test for OS from our data showed poor survival in GC patients with high SMARCE1 expression.

Abbreviations: GC, gastric cancer; NT, adjacent non-tumor tissues; TCGA, The Cancer Genome Atlas; TPM, transcripts per million.